Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Hepatitis B 2Whooping Cough 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Solid Tumor 1Pneumococcal Infections 1Neoplasm Metastasis 1Measles 1HIV Infections 1Gallstones 1Depression 1Condylomata Acuminata 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Colposcopy 18Imiquimod 14Conization 12Papillomavirus Vaccines 9Vaccines 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Papanicolaou Test 5Human Papillomavirus DNA Tests 5Blood Specimen Collection 5Watchful Waiting 4GX-188 vaccine 4Surveys and Questionnaires 3Cisplatin 3VGX-3100 2Transurethral Resection of Prostate 2Topotecan 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Indomethacin 2Immunohistochemistry 2Human Papillomavirus Recombinant Vaccine nonavalent 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × Hepatitis B Vaccines × Clear all
NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Xiamen University

Phase 2 Completed
1,600 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡